Literature DB >> 1824862

Astrocytes, not neurons, produce docosahexaenoic acid (22:6 omega-3) and arachidonic acid (20:4 omega-6).

S A Moore1, E Yoder, S Murphy, G R Dutton, A A Spector.   

Abstract

Elongated, highly polyunsaturated derivatives of linoleic acid (18:2 omega-6) and linolenic acid (18:3 omega-3) accumulate in brain, but their sites of synthesis are not fully characterized. To investigate whether neurons themselves are capable of essential fatty acid elongation and desaturation or are dependent upon the support of other brain cells, primary cultures of rat neurons and astrocytes were incubated with [1-14C] 18:2 omega-6, [1-14C]20:4 omega-6, [1-14C]18:3 omega-3, or [1-14C]20:5 omega-3 and their elongation/desaturation products determined. Neuronal cultures were routinely incapable of producing significant amounts of delta 4-desaturase products. They desaturated fatty acids very poorly at every step of the pathway, producing primarily elongation products of the 18- and 20-carbon precursors. In contrast, astrocytes actively elongated and desaturated the 18- and 20-carbon precursors. The major metabolite of 18:2 omega-6 was 20:4 omega-6, whereas the primary products from 18:3 omega-3 were 20:5 omega-3, 22:5 omega-3, and 22:6 omega-3. The majority of the long-chain fatty acids formed by astrocyte cultures, particularly 20:4 omega-6 and 22:6 omega-3, was released into the extracellular fluid. Although incapable of producing 20:4 omega-6 and 22:6 omega-3 from precursor fatty acids, neuronal cultures readily took up these fatty acids from the medium. These findings suggest that astrocytes play an important supportive role in the brain by elongating and desaturating omega-6 and omega-3 essential fatty acid precursors to 20:4 omega-6 and 22:6 omega-3, then releasing the long-chain polyunsaturated fatty acids for uptake by neurons.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1824862     DOI: 10.1111/j.1471-4159.1991.tb08180.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  66 in total

Review 1.  Essentiality of fatty acids.

Authors:  A A Spector
Journal:  Lipids       Date:  1999       Impact factor: 1.880

Review 2.  Maternal omega-3 fatty acid supplementation and risk for perinatal maternal depression.

Authors:  Janet M Wojcicki; Melvin B Heyman
Journal:  J Matern Fetal Neonatal Med       Date:  2010-10-07

3.  DHA inhibits ER Ca2+ release and ER stress in astrocytes following in vitro ischemia.

Authors:  Gulnaz Begum; Douglas Kintner; Yan Liu; Samuel W Cramer; Dandan Sun
Journal:  J Neurochem       Date:  2012-02       Impact factor: 5.372

4.  Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases.

Authors:  Nicolas G Bazan; Miguel F Molina; William C Gordon
Journal:  Annu Rev Nutr       Date:  2011-08-21       Impact factor: 11.848

Review 5.  Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses.

Authors:  Richard J Wurtman; Mehmet Cansev; Toshimasa Sakamoto; Ismael Ulus
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

Review 6.  Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phosphatides.

Authors:  R J Wurtman; M Cansev; I H Ulus
Journal:  J Nutr Health Aging       Date:  2009-03       Impact factor: 4.075

Review 7.  Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.

Authors:  Joanne J Liu; Pnina Green; J John Mann; Stanley I Rapoport; M Elizabeth Sublette
Journal:  Brain Res       Date:  2014-12-08       Impact factor: 3.252

8.  Elongation predominates over desaturation in the metabolism of 18:3n-3 and 20:5n-3 in turbot (Scophthalmus maximus) brain astroglial cells in primary culture.

Authors:  D R Tocher
Journal:  Lipids       Date:  1993-04       Impact factor: 1.880

9.  Effect of the delta6-desaturase inhibitor SC-26196 on PUFA metabolism in human cells.

Authors:  Shawn D Harmon; Terry L Kaduce; Tony D Manuel; Arthur A Spector
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

Review 10.  Metabolic pathways and activity-dependent modulation of glutamate concentration in the human brain.

Authors:  Silvia Mangia; Federico Giove; Mauro Dinuzzo
Journal:  Neurochem Res       Date:  2012-07-31       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.